- 【Toyama Prefecture】Issued Business Suspension Order to Nichi-Iko‐Inappropriate Manufacturing at Toyama Plant 1
2021年03月09日 (火) - 【MHLW】Publishing a list of drugs requiring stability protection‐506 items such as Cefazolin
2021年03月09日 (火) - 【MHLW】Requested for Preparation for Digitization of Package Insertsh‐GS1 Code Reading, etc.
2021年03月09日 (火) - 【Fukui Prefecture】Business Suspension Order to Kobayashi Kako Co., Ltd for 116 Days – Longest Ever, For Keeping Quiet about Manufacturing Conditions
2021年02月18日 (木) - 【METI】Technology strategies for practical use of biopharmaceuticals – Discussion at the review meeting in the next fiscal year
2021年02月18日 (木) - 【JPMA / NCBN】Joint research between industry-academia-government to create new drugs-Building an integrated database of disease-specific information
2021年02月18日 (木) - 【Government Strategy Council】Targeting Doubling of Bio-pharmaceutical Market – Specific Strategies for the Next 10 Years
2021年02月18日 (木) - 【MHLW】Pharmaceutical Production Value Is 9.5 Trillion Yen – Saitama Prefecture Is Top Producer
2021年01月22日 (金) - 【MHLW investigative commission 】Continuation of considering making online medical care permanent – to add these points to guidelines revision by the next fall.
2021年01月22日 (金) - Ministers Agreed on Off-year Revision – Settled on Coverage of “Deviation Rate of More than 5%”, Prices to be Reduced for 70% of All Products
2020年12月29日 (火) - 【MHLW】280 generic products listed in National Health Insurance （NHI） Price List‐“Lyrica” as the first generic drug and other drugs from 22 companies joined the list
2020年12月29日 (火) - Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients
2020年12月22日 (火) - 【Pharmaceutical Affairs Committee of the Japan Pharmaceutical Manufacturers Association】Discontinues Development, Unable to Acquire Designation as Orphan Drugs – Demand for Designation Criteria Equivalent to Europe and U.S.
2020年12月22日 (火) - 【Pharmaceutical Affairs and Food Sanitation Council】Recurrence Prevention Measures for the SMA Drug Issue‐Including Pre-evaluation of Application Data
2020年12月18日 (金) - 【Fukui Prefecture】Carried out On-site Investigation of Kobayashi Kako ‐ Health Problems Expanded to 128 Cases
2020年12月18日 (金)
TOP ∨
‐AD‐
※ １ページ目が最新の一覧
おすすめ情報‐AD‐
HEADLINE NEWS
ヘルスデーニュース‐FDA関連‐
新薬・新製品情報
企画
寄稿
